WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
Ozone Off-Gas: What It Reveals About System Efficiency, Safety, and Design
Learn how ozone off-gas impacts system efficiency, safety, and performance, and why monitoring and management are critical for optimized water treatment operations.
-
UK Reservoirs, Water Shortages, And Legionella Risks
Is there a clear link between a less plentiful water supply and an increase in Legionella in our domestic water systems?
-
The Devastating Legacy Of Algaecides: Why The Quick Fix Is Failing Our Lakes As warmer months approach, water management professionals must confront the compounding consequences of biocidal algae treatments.
-
What Is The Future Of Source Water Protection? Water utility managers and municipal leaders have long struggled amid the convergence of several threats to public water supplies. During a recent Water Online Live event, I sat with a panel of industry experts to examine the transition from reactive crisis management to a proactive, adaptive resilience framework.
-
Drinking Water Contaminated With 'Forever Chemicals' During Pregnancy Linked To An Increased Risk Of Childhood Asthma
While most of us are routinely exposed to low levels of PFAS, some communities are exposed to far higher levels from nearby pollution sources. A new study shows that in one of these at-risk communities, children were more likely to develop asthma if their mothers were exposed to very high PFAS levels during pregnancy.
-
The Pragmatic Shift In Source Water Protection: Moving From Symptom Management To Root-Cause Accountability A shift in how we approach source water protection is long overdue. Currently, we are trapped in a cycle of escalating costs, forced to treat symptoms like algae and invasive weeds expediently with chemicals while the underlying risk in the reservoir compounds. True risk management requires breaking this cycle.
-
The AWWA Said $2.4 Trillion. It Missed The Compound Interest. Einstein once said of compound interest, "He who understands it, earns it. He who doesn't, pays it." The same logic of compounding applies to the organic sediment accumulating on the floor of your drinking water reservoir. The longer you wait to address it, the more exponentially expensive it becomes to fix.
-
Designing Resilient PFAS Treatment Strategies For Water Agencies Water agencies across the U.S. are facing a rapidly evolving regulatory landscape for per- and polyfluoroalkyl substances (PFAS) that poses a conundrum: Should they take a cautious or aggressive approach to treating PFAS contamination in their water system?
-
The Future Of In Situ Chemical Oxidation For Targeted Solvent Destruction
The U.S. EPA’s 2026 trichloroethylene (TCE) compliance deadlines are now forcing a concrete shift toward source-zone destruction. In situ chemical oxidation (ISCO), sequenced with enhanced bioremediation, is proving to be the most credible path to groundwater contaminant rebound mitigation.
-
When Drinking Water Raises Bigger Questions About Brain Health And Environmental Risk
A new study linking certain groundwater sources to higher Parkinson’s risk underscores a broader question for the water sector: how environmental exposures in drinking water may influence long-term health.
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
The current state of the water infrastructure in the U.S. is in need of critical attention. Aging and underfunded systems, increasing demand, and the impacts of climate change are putting immense pressure on the nation’s ability to deliver this essential resource.
-
With the right help, coping with workforce upheaval, the digital transition, and asset management can be an opportunity.
-
Read more about how Fujifilm Diosynth Biotechnologies evaluated a prime filter with challenging simulant solutions and how the experimental data confirmed superior performance, which demonstrated twice the throughput.
-
PFAS rules are shifting fast. Learn how utilities can futureproof treatment strategies with flexible designs, smart staging, and emerging technologies—avoiding stranded assets and staying ahead of tomorrow’s regulations.
-
Discover how science-based bio-decontamination strategies effectively eliminate invisible pathogens and rapidly restore facilities to operational safety following major infrastructure disruptions.
-
High‑concentration biologic formulations for prefilled syringes and on‑body devices enable easier self‑administration, reduce treatment burden, boost adherence, and address complex formulation challenges.
-
Emerging state water reuse regulations are driving adoption of ozone and advanced oxidation, requiring flexible, high-performance systems to meet pathogen, trace organic, and DBP control objectives.
-
Relying on assumptions when designing water treatment systems creates unnecessary financial and operational risks. Adopting predictive modeling and data-driven testing provides the precise, actionable insights required to optimize performance, manage costs, and ensure compliance.
-
Microbial testing of environmental water demands efficient, contamination‑resistant workflows. Discover a membrane filtration technique that offers rapid, reliable colony isolation.
-
Color consistency improves surgical visibility, differentiation, and workflow efficiency, requiring medical textiles that deliver strength, compliance, and reliable quality in every color.
-
Single-future design assumptions are no longer sufficient. See what scenario modelling reveals about building treatment infrastructure that performs across decades of uncertainty.
-
Aging water storage tanks face stratification and stagnation, threatening water quality. Active mixing ensures uniform disinfectant distribution, reduces flushing, and improves system reliability and regulatory compliance.
-
Accurate dechlorination control requires monitoring all residual oxidants that threaten membrane integrity. Total chlorine analysis provides the necessary precision at ultra-low levels, ensuring comprehensive protection against oxidative damage while maintaining reagent stability during intermittent system operations.
-
AAV vectors hold promise for gene therapy, but removing product-related impurities remains a challenge. Learn how cell line development and process optimization are advancing rAAV production.
-
A CDMO guide to implementing EU Annex 1 for modern sterile fill/finish facilities, covering cleanroom design, contamination control, utilities, personnel, monitoring, and audit essentials.
-
Aseptic processing sterilizes products and packaging separately, then combines them in a sterile environment. See how this method ensures safety, extends shelf life, and protects medicines from contamination.
-
Filter fouling has limited exosome therapeutic scalability—until now. Explore how a breakthrough reagent achieves 50% particle recovery versus 5% traditionally, enabling affordable clinical manufacturing.
-
Breakthrough Therapy designation (BTD) can accelerate rare disease drug development—but timing and evidence are everything. Learn how to position your program for FDA success.